mhurhangee/ep-ind-claims huggingface dataset:
A method for transmitting system information performed by a base station, comprising: determining (101; 301) an identifier of each piece of currently supported second system information, wherein the first system information refers to the system information that is periodically broadcast by the base station, and each piece of second system information refers to the system information other than the system information comprised by the first system information; determining (102; 302) transmission status of each piece of second system information in accordance with the identifier of each piece of second system information; and broadcasting (103; 303) the first system information, wherein the first system information comprises the identifier and the transmission status of each piece of second system information; wherein the transmission status comprises a first transmission status and a second transmission status, the first transmission status is used for indicating that the corresponding second system information is being broadcast, and the second transmission status is used for indicating that the corresponding second system information is not being transmitted and for each of the plurality of pieces of second system information, when the transmission status of the second system information is the first transmission status, the first system information further comprises a transmission mode of the second system information, and the transmission mode is a broadcast mode. determining (101; 301) an identifier of each piece of currently supported second system information, wherein the first system information refers to the system information that is periodically broadcast by the base station, and each piece of second system information refers to the system information other than the system information comprised by the first system information; determining (102; 302) transmission status of each piece of second system information in accordance with the identifier of each piece of second system information; and broadcasting (103; 303) the first system information, wherein the first system information comprises the identifier and the transmission status of each piece of second system information; wherein the transmission status comprises a first transmission status and a second transmission status, the first transmission status is used for indicating that the corresponding second system information is being broadcast, and the second transmission status is used for indicating that the corresponding second system information is not being transmitted and for each of the plurality of pieces of second system information, when the transmission status of the second system information is the first transmission status, the first system information further comprises a transmission mode of the second system information, and the transmission mode is a broadcast mode.
A moisturizing composition for coating a wearable article, comprising: i. 10 to 30% by weight of at least one humectant, wherein the humectant is selected from the group consisting of glycerin, glycerol, polyhydric alcohol and mixtures thereof; ii. 1.0 to 5.4% by weight of at least one antioxidant, wherein the antioxidant is selected from the group consisting of vitamin E, tocopheryl acetate, α-tocopheryl acetate and mixtures thereof; and iii. 10 to 20% by weight of at least one emollient, wherein the emollient is selected from the group consisting of sweet almond oil ( prunus amygdalus dulcis), ceramide, shea butter and jojoba oil. i. 10 to 30% by weight of at least one humectant, wherein the humectant is selected from the group consisting of glycerin, glycerol, polyhydric alcohol and mixtures thereof; ii. 1.0 to 5.4% by weight of at least one antioxidant, wherein the antioxidant is selected from the group consisting of vitamin E, tocopheryl acetate, α-tocopheryl acetate and mixtures thereof; and iii. 10 to 20% by weight of at least one emollient, wherein the emollient is selected from the group consisting of sweet almond oil ( prunus amygdalus dulcis), ceramide, shea butter and jojoba oil.
A restriction endonuclease enzyme having an artificially introduced mutation and an overall fidelity index improvement factor of at least 2, wherein the restriction endonuclease absent the artificially introduced mutation is EcoRV and wherein the artificially introduced mutation corresponds to D19A; E27A; or D19A/E27A in SEQ ID No. 84.
Intraocular lens comprising a single optical part and comprising a haptic coupled to the optical part, and having a main optical axis which passes through a front side and a back side of the optical part, the haptic comprising a first haptic part which is in the form of a first ring and encircles the optical part, and at least one second haptic part which is in the form of a second ring and encircles the optical part and which is elastically movable relative to the first haptic part, at least one of the two rings (6, 11) having an uneven form in the circumferential direction about the main optical axis, characterized in that at least one of the two rings (6, 11) has exactly two ring valleys (8, 17, 12, 13) and exactly two ring peaks (9, 10, 14, 15).
Cylinder head having turbines (2a, 2b) arranged in parallel, which cylinder head - has at least two cylinders, with each cylinder having at least one outlet openings for discharging the exhaust gases out of the cylinder and with an exhaust line adjoining each outlet opening, and in which cylinder head - the exhaust lines of at least two cylinders converge into an overall exhaust line within the cylinder head so as to form an integrated exhaust manifold, characterized in that - two turbines (2a, 2b) which are arranged in parallel are provided downstream of the exhaust manifold, and - the two turbines (2a, 2b) have a common turbine housing which, for the supply of exhaust gas, is provided with an inlet region, a control element for splitting up the exhaust-gas flow between the two turbines (2a, 2b) being provided in the housing and the turbine housing being at least partially integrated in the cylinder head such that the cylinder head and at least a part of the turbine housing form a monolithic component. - has at least two cylinders, with each cylinder having at least one outlet openings for discharging the exhaust gases out of the cylinder and with an exhaust line adjoining each outlet opening, and in which cylinder head - the exhaust lines of at least two cylinders converge into an overall exhaust line within the cylinder head so as to form an integrated exhaust manifold, - two turbines (2a, 2b) which are arranged in parallel are provided downstream of the exhaust manifold, and - the two turbines (2a, 2b) have a common turbine housing which, for the supply of exhaust gas, is provided with an inlet region, a control element for splitting up the exhaust-gas flow between the two turbines (2a, 2b) being provided in the housing and the turbine housing being at least partially integrated in the cylinder head such that the cylinder head and at least a part of the turbine housing form a monolithic component.
Drinking straw comprising: - a plastic wall having an elongate container section; - liquid permeable closures closing off the container section at both ends; - at least one effervescent tablet disposed within the container section such that a clearance is left between the inner side of the wall and the at least one tablet; - a plurality of hygroscopic fillers disposed at both sides of the at least one tablet within the container section, serving as spacers in order to keep the at least one tablet at a distance from both ends. - a plastic wall having an elongate container section; - liquid permeable closures closing off the container section at both ends; - at least one effervescent tablet disposed within the container section such that a clearance is left between the inner side of the wall and the at least one tablet; - a plurality of hygroscopic fillers disposed at both sides of the at least one tablet within the container section, serving as spacers in order to keep the at least one tablet at a distance from both ends.
A method comprising simultaneously modulating a plurality of imaging pixels (211, 212, 213, 214, 215, 216, 217, 218, 219; 221,...) of a light sensor by a set of separate modulation signals, characterized in that the imaging pixels of the light sensor are simultaneously modulated in an imaging superpixel (251, 252, 253, 254) such that each imaging pixel in the imaging superpixel is modulated by a modulation signal that causes sensitivity of the imaging pixel to vary over time, wherein the pixels of the light sensor also include pixel sets (1, 2, 3, 4, 5, 6, 7, 8, 9) and each pixel set comprises multiple pixels to which a single modulation signal is applied, each of the pixel sets is modulated by a separate modulation signal and each superpixel includes at least one pixel from each of the pixel sets, so that different pixels in each superpixel are separately modulated.
A lubricating oil composition having a sulphated ash content of less than or equal to 1.2 mass % as determined by ASTM D874 and a phosphorus content of less than or equal to 0.12 mass % as determined by ASTM D5185, which lubricating oil composition comprises or is made by admixing: an oil of lubricating viscosity, in a major amount; an oil-soluble or oil-dispersible polymeric friction modifier as an additive in an effective minor amount of at least 0.1 mass % based on the total mass of the lubricating oil composition, the polymeric friction modifier being the reaction product of solely: (i) one or more functionalised polyolefins which is a poly(alkylene) functionalised with at least one diacid or anhydride functional group and wherein the poly(alkylene) of the functionalised polyolefin has a carbon chain length of from 50 to 500 carbon atoms; (ii) one or more polyalkylene glycols; (iii) one or more C 2 to C 20 aliphatic hydrocarbyl polyols; and, (iv) one or more polycarboxylic acids which is a C 2 to C 30 hydrocarbyl polycarboxylic acid; and, at least one oil-soluble or oil-dispersible dihydrocarbyl dithiophosphate metal salt as an additive in an effective minor amount providing the lubricating oil composition with at least 100 ppm by mass of phosphorus, based upon the total mass of the lubricating oil composition. an oil of lubricating viscosity, in a major amount; an oil-soluble or oil-dispersible polymeric friction modifier as an additive in an effective minor amount of at least 0.1 mass % based on the total mass of the lubricating oil composition, the polymeric friction modifier being the reaction product of solely: (i) one or more functionalised polyolefins which is a poly(alkylene) functionalised with at least one diacid or anhydride functional group and wherein the poly(alkylene) of the functionalised polyolefin has a carbon chain length of from 50 to 500 carbon atoms; (ii) one or more polyalkylene glycols; (iii) one or more C 2 to C 20 aliphatic hydrocarbyl polyols; and, (iv) one or more polycarboxylic acids which is a C 2 to C 30 hydrocarbyl polycarboxylic acid; and, (i) one or more functionalised polyolefins which is a poly(alkylene) functionalised with at least one diacid or anhydride functional group and wherein the poly(alkylene) of the functionalised polyolefin has a carbon chain length of from 50 to 500 carbon atoms; (ii) one or more polyalkylene glycols; (iii) one or more C 2 to C 20 aliphatic hydrocarbyl polyols; and, (iv) one or more polycarboxylic acids which is a C 2 to C 30 hydrocarbyl polycarboxylic acid; and, at least one oil-soluble or oil-dispersible dihydrocarbyl dithiophosphate metal salt as an additive in an effective minor amount providing the lubricating oil composition with at least 100 ppm by mass of phosphorus, based upon the total mass of the lubricating oil composition.
A therapeutic composition comprising a VSP (Variant Specific Surface Protein) carrier and a therapeutic agent, wherein: - said VSP carrier is a polypeptide comprising at least one CXXC motif, wherein C represents a cysteine amino acid and X represents any amino acid, and is selected from the group consisting of: • a VSP of Giardia; • a VSP-like protein of a microorganism selected from Paramecium or Tetrahymena or Entamoeba species; - said therapeutic agent is a biological agent, wherein the biological agent is a bioactive peptide, wherein the bioactive peptide is selected from the group consisting of insulin, human growth hormone, glucagon, parathormone, IL-2, IL-10 and a combination of two or more of said bioactive peptides; - said VSP carrier is bound to said therapeutic agent through (i) covalent non-peptide binding or (ii) non-covalent binding, provided that, when said VSP carrier is a VSP of Giardia said therapeutic agent is not insulin, human growth hormone, glucagon. - said VSP carrier is a polypeptide comprising at least one CXXC motif, wherein C represents a cysteine amino acid and X represents any amino acid, and is selected from the group consisting of: • a VSP of Giardia; • a VSP-like protein of a microorganism selected from Paramecium or Tetrahymena or Entamoeba species; • a VSP of Giardia; • a VSP-like protein of a microorganism selected from Paramecium or Tetrahymena or Entamoeba species; - said therapeutic agent is a biological agent, wherein the biological agent is a bioactive peptide, wherein the bioactive peptide is selected from the group consisting of insulin, human growth hormone, glucagon, parathormone, IL-2, IL-10 and a combination of two or more of said bioactive peptides; - said VSP carrier is bound to said therapeutic agent through (i) covalent non-peptide binding or (ii) non-covalent binding, provided that, when said VSP carrier is a VSP of Giardia said therapeutic agent is not insulin, human growth hormone, glucagon.
A method of fastening a rivet element to a workpiece, in particular to a sheet metal part, which has a preshaped hole provided for the reception of a rivet section of the rivet element and which is made planar at least in the region around the preshaped hole, wherein, prior to the fastening process, the workpiece is positioned at a well-defined spacing from a contact surface of a die by means of at least one movable and/or elastic spacer of the die for reshaping the rivet section so that a gap is formed between a wall of the hole and a punch of the die which is provided for the reshaping of the rivet section, and wherein the rivet section is introduced into the gap in the course of the fastening process and is reshaped by the punch in order to engage behind the workpiece in the region of the hole, characterized in that the workpiece is only moved toward the contact surface after the start of a reshaping of the rivet section.
A fuel cell module comprising a fuel cell stack formed by stacking electrolyte electrode assemblies and non-end separators alternately in a stacking direction, the electrolyte electrode assemblies each including an anode, a cathode, and an electrolyte interposed between the anode and the cathode, a fuel gas channel for supplying a fuel gas along an electrode surface of the anode being formed on one surface of the non-end separator and an oxygen-containing gas channel for supplying an oxygen-containing gas along an electrode surface of the cathode being formed on the other surface of the non-end separator, wherein a fuel gas inlet for supplying the fuel gas into the fuel gas channel is formed in the non-end separator; wherein the electrolyte electrode assembly and a first end separator are provided at one end of the fuel cell stack in the stacking direction, the first end separator being provided outside the electrolyte electrode assembly in the stacking direction, the first end separator being configured to allow supply of the oxygen-containing gas to the oxygen-containing gas channel; and a dummy electrolyte electrode assembly (86; 180) and a second end separator are provided at another end of the fuel cell stack in the stacking direction, the second end separator being provided outside the dummy electrolyte electrode assembly (86; 180) in the stacking direction, the dummy electrolyte electrode assembly (86; 180) having a shape that is similar to that of the electrolyte electrode assembly, having electrical conductivity, but not having a power generation function, wherein the fuel gas inlet is not formed in the first and second end separators so as to limit supply of the fuel gas to the fuel gas channel, characterized in that the dummy electrolyte electrode assembly (86; 180) is a stack body formed by stacking a ceramic felt and an electrically conductive metal plate. wherein the fuel gas inlet is not formed in the first and second end separators so as to limit supply of the fuel gas to the fuel gas channel, characterized in that the dummy electrolyte electrode assembly (86; 180) is a stack body formed by stacking a ceramic felt and an electrically conductive metal plate.
A state processing method for controlling a state of a secondary cell, performed by a user equipment, the method comprising: receiving state configuration information sent by a base station; and said method being characterized by further comprising: determining, based on the state configuration information, whether to set an initial state of the secondary cell and an initial state of a Bandwidth Part, BWP, associated with the secondary cell to a new state, wherein the new state is a state between an activated state and a deactivated state, and a quantity of secondary cells configured by the base station for the user equipment is at least one.
Method for determining the mass and conveying speed of bulk materials in a linear conveyor, the bulk material reaching a conveying channel via an opening of a bulk material container, characterized in that a discontinuity in the constant profile of the signal of a sensor is generated by a change in mass of the conveyed bulk material, and the torque of the weight of the conveyed bulk material is established by means of the sensor, the generated signal change being evaluated in order to determine the mass and/or the speed of the conveyed bulk material.
A smoking article for use in an aerosol-generating device, the smoking article comprising: an aerosol-forming substrate located at an extreme upstream end of the smoking article; and a support element located immediately downstream of the aerosol-forming substrate, wherein the aerosol-forming substrate comprises a gathered crimped sheet of homogenised tobacco material having a plurality of substantially parallel ridges or corrugations, the substantially parallel ridges or corrugations extending along or parallel to the longitudinal axis of the smoking article, said tobacco material thereby beingconfigured to be penetrable by a heating element of an aerosol-generating device having a diameter of between about 40 percent and about 70 percent of the diameter of the aerosol-forming substrate without bending of the smoking article by more than 7 degrees relative to the longitudinal axis of the smoking article and without tearing or ripping of an outer wrapper of the smoking article, and wherein the support element abuts the aerosol-forming substrate, the support element being configured to resist downstream movement of the aerosol-forming substrate during insertion of the heating element of the aerosol-generating device into the aerosol-forming substrate. an aerosol-forming substrate located at an extreme upstream end of the smoking article; and a support element located immediately downstream of the aerosol-forming substrate,
A skin treatment apparatus, comprising: a microwave source for generating microwave electromagnetic energy; an applicator for mounting over a region of skin, the applicator comprising: a waveguide for conveying the microwave electromagnetic energy; and a microwave feed structure coupled between the microwave source and the waveguide for launching the microwave electromagnetic energy into the energy delivery structure, wherein the apparatus is controllable to deliver the microwave electromagnetic energy in a manner that induces a thermal profile in the region of skin, the thermal profile having a maximum temperature that occurs at a predetermined distance beneath a surface of the region of skin, wherein the waveguide includes a treatment aperture for locating over the region of skin, the treatment aperture being dimensioned to emit the microwave electromagnetic energy as an electromagnetic field, wherein the waveguide comprises an interior wall adjacent the treatment aperture and a microwave shield disposed on the interior wall and covering or occupying part or parts of the interior wall, and wherein the microwave shield is arranged to shape the emitted microwave electromagnetic energy as a uniform electromagnetic field across the treatment aperture. a microwave source for generating microwave electromagnetic energy; an applicator for mounting over a region of skin, the applicator comprising: a waveguide for conveying the microwave electromagnetic energy; and a microwave feed structure coupled between the microwave source and the waveguide for launching the microwave electromagnetic energy into the energy delivery structure, a waveguide for conveying the microwave electromagnetic energy; and a microwave feed structure coupled between the microwave source and the waveguide for launching the microwave electromagnetic energy into the energy delivery structure, wherein the apparatus is controllable to deliver the microwave electromagnetic energy in a manner that induces a thermal profile in the region of skin, the thermal profile having a maximum temperature that occurs at a predetermined distance beneath a surface of the region of skin, wherein the waveguide includes a treatment aperture for locating over the region of skin, the treatment aperture being dimensioned to emit the microwave electromagnetic energy as an electromagnetic field, wherein the waveguide comprises an interior wall adjacent the treatment aperture and a microwave shield disposed on the interior wall and covering or occupying part or parts of the interior wall, and wherein the microwave shield is arranged to shape the emitted microwave electromagnetic energy as a uniform electromagnetic field across the treatment aperture.
A clotting factor comprising a recombinant Factor IX (rFIX) polypeptide and a Fc region (FIX-Fc), for use in a method of reducing, ameliorating, or preventing one or more symptoms of hemophilia B in human subjects in need thereof, wherein the method comprises administering the clotting factor to the subjects as a fixed dose that is standard across all body weights, and wherein the fixed dose is administered once weekly or once every 10 days at a dose of about 4,000 IU, or wherein the fixed dose is administered once every 10 days at a dose between about 6,000 IU and about 8,000 IU, and wherein the clotting factor comprises: (i) a first polypeptide chain comprising a FIX-Fc amino acid sequence having at least 95% sequence identity to the amino acid sequence according to SEQ ID NO: 2; and (ii) a second polypeptide chain comprising an Fc amino acid sequence having at least 95% sequence identity to the amino acid sequence according to SEQ ID NO: 4. wherein the fixed dose is administered once weekly or once every 10 days at a dose of about 4,000 IU, or wherein the fixed dose is administered once every 10 days at a dose between about 6,000 IU and about 8,000 IU, and wherein the clotting factor comprises: (i) a first polypeptide chain comprising a FIX-Fc amino acid sequence having at least 95% sequence identity to the amino acid sequence according to SEQ ID NO: 2; and (ii) a second polypeptide chain comprising an Fc amino acid sequence having at least 95% sequence identity to the amino acid sequence according to SEQ ID NO: 4. (i) a first polypeptide chain comprising a FIX-Fc amino acid sequence having at least 95% sequence identity to the amino acid sequence according to SEQ ID NO: 2; and (ii) a second polypeptide chain comprising an Fc amino acid sequence having at least 95% sequence identity to the amino acid sequence according to SEQ ID NO: 4.